MX2015009155A - Uso de agonistas del receptor nicotinico de acetilcolina alfa 7. - Google Patents
Uso de agonistas del receptor nicotinico de acetilcolina alfa 7.Info
- Publication number
- MX2015009155A MX2015009155A MX2015009155A MX2015009155A MX2015009155A MX 2015009155 A MX2015009155 A MX 2015009155A MX 2015009155 A MX2015009155 A MX 2015009155A MX 2015009155 A MX2015009155 A MX 2015009155A MX 2015009155 A MX2015009155 A MX 2015009155A
- Authority
- MX
- Mexico
- Prior art keywords
- alpha
- acetylcholine receptor
- nicotinic acetylcholine
- receptor agonists
- facilitation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Emergency Medicine (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invención se refiere al uso de cierto agonista del receptor nicotínico de acetilcolina alfa 7 para facilitar la recuperación de la anestesia general.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361752772P | 2013-01-15 | 2013-01-15 | |
PCT/IB2014/058225 WO2014111838A1 (en) | 2013-01-15 | 2014-01-13 | Use of alpha 7 nicotinic acetylcholine receptor agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015009155A true MX2015009155A (es) | 2016-03-04 |
Family
ID=50070639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015009155A MX2015009155A (es) | 2013-01-15 | 2014-01-13 | Uso de agonistas del receptor nicotinico de acetilcolina alfa 7. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2945633B1 (es) |
JP (1) | JP6338223B2 (es) |
KR (1) | KR101879920B1 (es) |
CN (1) | CN105263495B (es) |
BR (1) | BR112015016995B8 (es) |
CA (1) | CA2898080C (es) |
ES (1) | ES2883232T3 (es) |
MX (1) | MX2015009155A (es) |
TW (1) | TWI633886B (es) |
WO (1) | WO2014111838A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111499615B (zh) | 2017-08-04 | 2024-02-02 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
US20210077478A1 (en) * | 2017-11-22 | 2021-03-18 | The Governors Of The University Of Alberta | Method of countering respiratory depression via activation of neuronal heteromeric nicotinic acetylcholine receptors |
CN118812532A (zh) | 2019-02-05 | 2024-10-22 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
KR20210135507A (ko) | 2019-02-06 | 2021-11-15 | 스카이호크 테라퓨틱스, 인코포레이티드 | 스플라이싱을 조절하는 방법 및 조성물 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6953855B2 (en) | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
GB0010955D0 (en) | 2000-05-05 | 2000-06-28 | Novartis Ag | Organic compounds |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
GB0220581D0 (en) * | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
KR101129933B1 (ko) | 2002-09-25 | 2012-03-23 | 메모리 파마슈티칼스 코포레이션 | 인다졸, 벤조티아졸 및 벤조이소티아졸 및 그의 제조 및용도 |
EP1824848A1 (en) | 2004-12-10 | 2007-08-29 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
US20050245531A1 (en) | 2003-12-22 | 2005-11-03 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
GB0412019D0 (en) | 2004-05-28 | 2004-06-30 | Novartis Ag | Organic compounds |
PE20060437A1 (es) | 2004-06-18 | 2006-06-08 | Novartis Ag | COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR |
GB0415746D0 (en) * | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
GB0521508D0 (en) | 2005-10-21 | 2005-11-30 | Novartis Ag | Organic compounds |
GB0525672D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
TW200813067A (en) | 2006-05-17 | 2008-03-16 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
UA92083C2 (ru) | 2006-05-19 | 2010-09-27 | Эбботт Леборетриз | Азабициклические алкановые производные, замещенные конденсированным бициклогетероциклом |
US8314119B2 (en) | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
CN100448468C (zh) * | 2006-11-14 | 2009-01-07 | 赵玉民 | 一种口服用于治疗胃病的药粉 |
SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
WO2009066107A1 (en) | 2007-11-21 | 2009-05-28 | Astrazeneca Ab | Use of a nicotinic receptor agonist |
JP5425915B2 (ja) | 2008-10-13 | 2014-02-26 | エフ.ホフマン−ラ ロシュ アーゲー | 二環5−(トリフルオロメトキシ)−1h−3−インダゾールカルボン酸アミドの合成におけるインダゾール中間体のジアゾニウムフリーの製造方法 |
WO2010056622A1 (en) | 2008-11-11 | 2010-05-20 | Targacept, Inc. | TREATMENT WITH ALPHA α7-SELECTIVE LIGANDS |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
JO3250B1 (ar) * | 2009-09-22 | 2018-09-16 | Novartis Ag | إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7 |
SG190686A1 (en) * | 2010-11-10 | 2013-07-31 | Lundbeck & Co As H | Radiolabelled phenylimidazole-based ligands |
JP2014503568A (ja) * | 2011-01-27 | 2014-02-13 | ノバルティス アーゲー | ニコチン酸アセチルコリン受容体α7活性化因子の使用 |
JPWO2013002365A1 (ja) * | 2011-06-30 | 2015-02-23 | 東レ株式会社 | 止痒剤 |
-
2014
- 2014-01-13 ES ES14703426T patent/ES2883232T3/es active Active
- 2014-01-13 CN CN201480014741.3A patent/CN105263495B/zh active Active
- 2014-01-13 BR BR112015016995A patent/BR112015016995B8/pt active IP Right Grant
- 2014-01-13 WO PCT/IB2014/058225 patent/WO2014111838A1/en active Application Filing
- 2014-01-13 MX MX2015009155A patent/MX2015009155A/es unknown
- 2014-01-13 EP EP14703426.8A patent/EP2945633B1/en active Active
- 2014-01-13 KR KR1020157021931A patent/KR101879920B1/ko active IP Right Grant
- 2014-01-13 CA CA2898080A patent/CA2898080C/en active Active
- 2014-01-13 JP JP2015552186A patent/JP6338223B2/ja active Active
- 2014-01-14 TW TW103101309A patent/TWI633886B/zh active
Also Published As
Publication number | Publication date |
---|---|
CA2898080C (en) | 2018-01-09 |
CN105263495B (zh) | 2019-05-14 |
WO2014111838A1 (en) | 2014-07-24 |
CA2898080A1 (en) | 2014-07-24 |
CN105263495A (zh) | 2016-01-20 |
BR112015016995A8 (pt) | 2018-01-23 |
JP6338223B2 (ja) | 2018-06-06 |
BR112015016995B8 (pt) | 2022-07-26 |
EP2945633A1 (en) | 2015-11-25 |
TWI633886B (zh) | 2018-09-01 |
BR112015016995B1 (pt) | 2022-02-01 |
JP2016509595A (ja) | 2016-03-31 |
BR112015016995A2 (pt) | 2017-07-11 |
KR20150105469A (ko) | 2015-09-16 |
TW201440766A (zh) | 2014-11-01 |
EP2945633B1 (en) | 2021-06-30 |
KR101879920B1 (ko) | 2018-07-18 |
ES2883232T3 (es) | 2021-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201904616B (en) | Glp-1 receptor agonists and uses thereof | |
HK1257647A1 (zh) | 使用fxr促效劑之方法 | |
HK1257649A1 (zh) | 使用fxr激動劑的方法 | |
HK1255163A1 (zh) | 作為apj受體激動劑的雜芳基羥基嘧啶酮 | |
MX2017006320A (es) | Terapia combinada que comprende agonistas de unión de ox40 y antagonistas de unión del eje de pd-1. | |
MX2015008999A (es) | Inhibidores mk2 y usos de los mismos. | |
AP2016009485A0 (en) | Compounds and compositions as toll-like receptor 7 agonists | |
ZA201807351B (en) | Novel gpr119 agonist compounds | |
HK1257648A1 (zh) | Fxr促效劑之使用方法 | |
EP3718557A3 (en) | Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing | |
PH12018502274A1 (en) | Semaglutide in cardiovascular conditions | |
EP3160961A4 (en) | Small molecule agonists of neurotensin receptor 1 | |
MX2015009155A (es) | Uso de agonistas del receptor nicotinico de acetilcolina alfa 7. | |
PL3019242T3 (pl) | Kompozycje i sposoby leczenia zaburzeń neuropsychiatrycznych przy zastosowaniu agonisty receptora endoteliny-B | |
GB201619637D0 (en) | C3a receptor agonists | |
PH12018501844A1 (en) | Liraglutide in cardiovascular conditions | |
MX2015009153A (es) | Uso de agonistas del receptor nicotinico de acetilcolina alfa 7. | |
IL264406B (en) | Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors | |
GB201816747D0 (en) | Linear apelin receptor agonists | |
AU2015902112A0 (en) | Agonists and antagonists for protease activated receptor 2 (PAR2) |